CD19 Antilichaam [SJ25-C1] (FITC)

CD19 is a type I transmembrane glycoprotein and a member of the immunoglobulin superfamily. It is expressed at all stages of B cell differentiation except terminally differentiated plasma cells. It is also present on the cell surface of follicular dendritic cells. CD19 associates with CD21, CD81, Leu 13 and/or MHC Class II molecules to form a signal transduction complex on the B cell surface. This signaling complex modulates the activation threshold for the B cell antigen receptor (BCR) .

930

P15391

P15391

Human

NALM-1 and NALM-16 leukemia cell line

[SJ25-C1]

FITC

Primary Antibodies

Cancer, Immunology, Signal Transduction

Batch dependent

Supplied in PBS/NaN3

None

Blue Ice

Store vial at 2-8˚ C

IgG1

CD19

CD19 Antibody [SJ25-C1] for use in flow cytometry and immunohistochemistry assays.

CD19

B-lymphocyte antigen CD19

Homo sapiens

B4, B-lymphocyte antigen, Leu-12

IHC, Flow, Blocking, IP, Depletion, Activity, Complement Mediated Cell Depletion

Liquid